Diagnostics Revolutions

Diagnostics Revolutions
  • Pininvest Analysis

By highlighting well respected companies providing systems for in-vitro diagnostics, including gene sequencing machines, and related services, we focus on advanced medical equipment used in clinical applications, in laboratories and in research.

The fastest growing areas, gene analysis techniques and splicing applied to fields of human identity testing, oncology research, infectious disease research, pharmacogenomics, and inherited disease boost research and product innovation in molecular biology (identifying potential drug targets), microbiology (defining how organisms evolve), medicine (tracking genetic diseases) and plant sciences

The breath of the applications with potential breakthrough in areas as diverse as healthcare, agriculture or environmental protection has opened vast opportunities for start-up companies applying the new technologies… but major uncertainties about commercial break-through leaves the potential investor exposed to extreme risk situations

To service the diagnostics market (evaluated at $ 60 billion and expected to continue to grow by 4% during the coming 5 years), manufacturers of the advanced medical equipment are placed on a strong footing

Diagnostics Revolutions • Updated:

Name Ticker Exchange Sector Industry Currency Cur.Price Mkt.Cap Perf. Vol. Risk Contrib. MDD
 
Accelerate Diagnostics AXDX NASDAQ Health Care Lab Analytical Instruments USD 18.29 997 M -17.1% 55%   3% -58%
Agilent Technologies A NYSE Health Care Medical Laboratories & Research USD 71.08 22 B 10.9% 28%   3% -20%
Bio-Rad Laboratories BIO NYSE Health Care Lab Analytical Instruments USD 327.50 10 B 3.5% 30%   2% -33%
Bio-Techne TECH NASDAQ Health Care Diagnostics USD 197.57 7.5 B 10.2% 28%   2% -35%
Bruker Corporation BRKR NASDAQ Health Care Lab Analytical Instruments USD 41.47 6.5 B 21.7% 33%   3% -22%
Cancer Genetics CGIX NASDAQ Health Care Diagnostics USD 0.11 6.6 M -89.2% 145%   0% -91%
Danaher DHR NYSE Conglomerates Industrial Conglomerates USD 140.35 101 B 40.0% 21%   2% -13%
Exact Sciences EXAS NASDAQ Health Care Diagnostics USD 119.82 15 B 145.3% 56%   11% -32%
Genomic Health GHDX NASDAQ Health Care Diagnostics USD 74.64 2.8 B 36.2% 49%   5% -43%
Guardant Health GH NASDAQ Health Care Diagnostics USD 101.52 9.4 B 215.3% 79%   21% -35%
HTG Molecular Diagnostics HTGM NASDAQ Health Care Specialized Medical Devices USD 1.00 29 M -69.7% 67%   1% -82%
Illumina ILMN NASDAQ Health Care Gene Editing - Cell Therapies USD 286.17 42 B -12.2% 39%   3% -26%
Laboratory Corporation Of America LH NYSE Health Care Diagnostics USD 166.15 16 B -8.8% 25%   2% -34%
NanoString Technologies NSTG NASDAQ Health Care Diagnostics USD 27.57 977 M 96.9% 51%   6% -24%
NeoGenomics NEO NASDAQ Health Care Medical Laboratories & Research USD 25.24 2.4 B 99.2% 41%   6% -39%
OPKO Health OPK NASDAQ Health Care Diagnostics USD 1.96 1.2 B -65.1% 76%   1% -70%
Pacific Biosciences of California PACB NASDAQ Health Care Medical Technology USD 5.76 879 M 37.5% 61%   4% -33%
Perkinelmer PKI NYSE Health Care Lab Analytical Instruments USD 82.34 9.1 B -3.2% 29%   3% -26%
Quest Diagnostics Inc. DGX NYSE Health Care Diagnostics USD 100.60 14 B -7.9% 24%   1% -28%
Quidel Corp QDEL NASDAQ Health Care Diagnostics USD 61.57 2.5 B -13.2% 44%   3% -42%
Sonic Healthcare SKHHY OTC Health Care Diagnostics USD 18.62 - 3.5% 21%   1% -20%
Thermo Fisher Scientific TMO NYSE Health Care Lab Analytical Instruments USD 276.15 110 B 20.4% 23%   3% -17%
Veracyte VCYT NASDAQ Health Care Gene Editing - Cell Therapies USD 25.64 1.1 B 119.5% 65%   11% -23%
Waters Corp. WAT NYSE Health Care Lab Analytical Instruments USD 205.54 14 B 9.6% 28%   2% -21%